📑jeringa descartable c/aguja, tiras testigo autoclave, brazalete p/aparato presion
Procurement process summary
This process is to purchase jeringa descartable c/aguja, tiras testigo autoclave, brazalete p/aparato presion.
This contract was awarded by 🇺🇾 NO VIGENTE Instituto Nacional del Cáncer for an amount of UYU 21,377,656 to 1 supplier. It was published on 2002-09-05 through not reported
Transparency in this process is reflected in the detailed publication of all aspects of the contract and its results.
Buying entity🇺🇾 NO VIGENTE Instituto Nacional del Cáncer Buying unitnot reported Publication date2002-09-05 Contest statusnot reported DescriptionR/212385690017Awards
This award was granted to UNION DISPROFARMA SOCIEDAD ANONIMA by NO VIGENTE Instituto Nacional del Cáncer for an amount of UYU 21,377,656. The procurement process was conducted through Not available for the category of Not available. The award was granted on 2002-08-26.
| Supplier | Amount | Award date |
|---|---|---|
| 🇺🇾 UNION DISPROFARMA SOCIEDAD ANONIMA | UYU 21,377,656 | 2002-08-26 |
Market context and opportunities
The execution of this contract allows the entity NO VIGENTE Instituto Nacional del Cáncer to fulfill its public service objectives efficiently.
Transparency in this process is reflected in the detailed publication of all aspects of the contract and its results.
This transparency in public procurement promotes fair competition, prevents corruption, and ensures that public resources are used efficiently for the benefit of citizens.
Additional data
Contract NumberUY_ocds-yfs5dr-a12198-R-212385690017Publication date2002-09-05Contract datenot reportedAward date2002-08-26Categoriesnot reportedPurchase modalitynot reportedMethod detailsnot reportedStatusnot reportedData sources
Sociedad.info publishes data from official sources, in compliance with public information access laws. Public access to this data is a civic right that helps hold government accountable. This data, including names and identifiers, is already public in the official source. Read our privacy policy.
